GentiBio
Last updated: May 09, 2024
Adel Nada, co-founder and CEO
Country: USA | Funding: $177M (+)
Website: http://www.gentibio.com/
GentiBio is a biotherapeutics company developing engineered regulatory T cells (EngTregs) programmed to treat autoimmune allergic diseases.
Website: http://www.gentibio.com/
GentiBio is a biotherapeutics company developing engineered regulatory T cells (EngTregs) programmed to treat autoimmune allergic diseases.